Contents

Search


immunoglobulin superfamily member 1 (inhibin-binding protein, inhBP, immunoglobulin-like domain-containing protein 1, Pituitary gland specific factor 2, p120, IGSF1, IGDC1, KIAA0364, PGSF2)

Function: - seems to be a coreceptor in inhibin signaling, but seems not to be a high-affinity inhibin receptor - antagonizes activin A signaling in the presence or absence of inhibin B (putative) - necessary to mediate a specific antagonistic effect of inhibin B on activin-stimulated transcription - interacts with INHA (putative) - interacts with ACVR1B, interaction appears to be ligand- dependent as it is diminished by inhibin B & activin A - interacts with ACVR2A, ACVR2B, ACVRL1 & BMPR1B Structure: - contains 12 Ig-like C2-type domain (immunoglobulin-like) Compartment: - isoforms 1 & 2: membrane - isoform 3: secreted (putative) Alternative splicing: - named isoforms=3 - additional isoforms seem to exist Expression: - highly expressed in pancreas, testis & fetal liver - moderately expressed in heart, prostate & small intestine - expressed at very low levels in brain, thymus, ovary, colon, fetal lung & fetal kidney - expressed in muscle - isoform 3 is expressed in pituitary gland

General

glycoprotein immunoglobulin superfamily protein membrane protein

Properties

SIZE: entity length = 1325 aa MW = 148 kD COMPARTMENT: cellular membrane MOTIF: exoplasmic domain {1-507} MOTIF: signal sequence {1-17} immunoglobulin superfamily domain {27-111} N-glycosylation site {N42} cysteine residue {C47} MODIFICATION: cysteine residue {C95} cysteine residue {C95} MODIFICATION: cysteine residue {C47} immunoglobulin superfamily domain {126-211} immunoglobulin superfamily domain {215-301} cysteine residue {C237} MODIFICATION: cysteine residue {C285} cysteine residue {C285} MODIFICATION: cysteine residue {C237} immunoglobulin superfamily domain {310-397} N-glycosylation site {N327} cysteine residue {C332} MODIFICATION: cysteine residue {C381} N-glycosylation site {N363} N-glycosylation site {N370} cysteine residue {C381} MODIFICATION: cysteine residue {C332} immunoglobulin superfamily domain {408-489} cysteine residue {C430} MODIFICATION: cysteine residue {C473} cysteine residue {C473} MODIFICATION: cysteine residue {C430} transmembrane domain {508-528} cytoplasmic loop {529-548} transmembrane domain {549-569} exoplasmic domain {570-1325} MOTIF: immunoglobulin superfamily domain {578-666} N-glycosylation site {N596} immunoglobulin superfamily domain {675-749} cysteine residue {C692} MODIFICATION: cysteine residue {C739} N-glycosylation site {N736} cysteine residue {C739} MODIFICATION: cysteine residue {C692} immunoglobulin superfamily domain {766-858} N-glycosylation site {N787} cysteine residue {C788} MODIFICATION: cysteine residue {C838} N-glycosylation site {N835} cysteine residue {C838} MODIFICATION: cysteine residue {C788} immunoglobulin superfamily domain {862-947} cysteine residue {C884} MODIFICATION: cysteine residue {C931} N-glycosylation site {N928} cysteine residue {C931} MODIFICATION: cysteine residue {C884} immunoglobulin superfamily domain {954-1049} N-glycosylation site {N975} N-glycosylation site {N1016} immunoglobulin superfamily domain {1054-1139} N-glycosylation site {N1071} cysteine residue {C1076} MODIFICATION: cysteine residue {C1123} cysteine residue {C1123} MODIFICATION: cysteine residue {C1076} N-glycosylation site {N1136} immunoglobulin superfamily domain {1150-1231} cysteine residue {C1172} MODIFICATION: cysteine residue {C1215} N-glycosylation site {N1212} cysteine residue {C1215} MODIFICATION: cysteine residue {C1172}

Database Correlations

OMIM 300137 UniProt Q8N6C5

References

UniProt :accession Q8N6C5